General Information
Revision date
2015-03-06
Product name
Etopophos for Injection
Product Synonyms
Etoposide Phosphate For Injection; BMY 40481 for Injection
CAS No.
117091-64-2
1.2.1 Relevant identified uses
This material is a finished drug product for patient use. It is used in the treatment of cancer
Emergency telephone
Australia (Sydney) +(61)-290372994
Icons in SDS
Company Information
company name
Bristol-Myers Squibb Australia Pty Ltd
GHS Information
Signal word
Danger
Section 2
SECTION 2: Hazards identification
UN Globally Harmonized System (GHS)
2.1 Classification of the substance or mixture
Germ Cell Mutagenicity - Category 1B Carcinogenicity - Category 1A Toxic To Reproduction - Male Reproductive Toxicity - Category 1A Toxic To Reproduction - Female Reproductive Toxicity - Category 1A Toxic To Reproduction - Developmental Toxicity - Category 1A Specific Target Organ Systemic Toxicity (Repeated Exposure) - Category 1
Signal word
Danger
Hazard statements
May damage fertility (female reproductive toxicity) . May cause genetic defects. May cause cancer. May damage fertility (male reproductive toxicity) . May damage the unborn child (developmental toxicity) . Causes damage to organs (bone marrow, gastrointestinal tract, peripheral nervous system, lymphatic system, cardiovascular system, female reproductive organs, male reproductive organs) through prolonged or repeated exposure.
Precautionary statements
Do not breathe dust. Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Use personal protective equipment as required. Wash thoroughly after handling. Do not eat, drink or smoke when using this product.
